NIH-funded research R03 grant

Investigating brain activity patterns in schizophrenia and related mouse models

Official title: Spectral Components of Abnormal Spontaneous Gamma Activity in Schizophrenia and Translational Mouse Models

Funded at Boston VA Research Institute, INC. · NIH-11139127 · Data updated 2026-11-12

This study is looking at how brain activity works in people with schizophrenia compared to those without, to better understand the brain's balance of signals and how it might affect thinking and behavior.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionBoston VA Research Institute, INC.
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 1, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$128,000
NIH project number1R03MH137541-01A1
Project IDNIH-11139127 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with schizophrenia or related neuropsychiatric disorders.

Less likely to help

Patients without a diagnosis of schizophrenia or those with unrelated cognitive impairments may not benefit from this research.

What this research studies

This research explores the spontaneous gamma activity in the brain, which is linked to the balance of excitation and inhibition in the cortex. By using advanced techniques like optogenetic stimulation and receptor blockade, the study aims to understand how these brain activity patterns differ in individuals with schizophrenia compared to healthy individuals. The research also examines the underlying neural mechanisms of these patterns and their potential role in cognitive functions. This could provide insights into the biological basis of schizophrenia and related disorders.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for schizophrenia and related cognitive disorders.

How similar studies have gone: Previous research has shown promising results in understanding gamma activity in neuropsychiatric disorders, indicating that this approach may yield valuable insights.

Where this research is happening

  • Boston VA Research Institute, INC.
    Boston, United States
    Active

Researchers

  • Principal investigator: Spencer, Kevin M — Boston VA Research Institute, INC.
  • Study coordinator: Spencer, Kevin M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.